CD94: The Assembly Switch That Sets NK Cell Receptor Direction
Natural killer cells decide between tolerance and attack using a large receptor repertoire, and CD94 sits at one of the most instructive junctions in that repertoire. The same glycoprotein can assemble into an inhibitory receptor or an activating one depending on which NKG2 subunit it partners with. That assembly logic makes CD94 both a useful phenotyping marker and a difficult one to interpret in isolation. This review covers the molecular biology, the genetic evidence from knockout models and the practical design of flow cytometry panels.
A C-Type Lectin With an Unusual Topology
CD94 is a type II transmembrane glycoprotein of the C-type lectin family, encoded by KLRD1. Its orientation is reversed relative to most surface receptors, with the N-terminus inside the cell and the lectin domain outside.
Expression is concentrated on natural killer cells and on a subset of CD8 positive T cells. Within the NK compartment it appears early and persists through maturation, which makes it convenient for gating strategies.
CD94 has no signaling motif of its own. Everything it does depends on the subunit it associates with, and that dependence is the defining feature of the receptor family.
How Assembly Determines Inhibitory or Activating Function
In cells that express both partners, CD94 forms disulfide-linked heterodimers with NKG2A, NKG2C, NKG2E or NKG2F. The choice of partner is made during biosynthesis and is not interchangeable at the surface.
Partnering with NKG2A produces an inhibitory receptor. The NKG2A cytoplasmic tail carries immunoreceptor tyrosine-based inhibitory motifs that recruit phosphatases and dampen activating signals.
Partnering with NKG2C or NKG2E produces an activating receptor. These subunits lack intrinsic signaling capacity and instead associate with DAP12, whose immunoreceptor tyrosine-based activation motifs recruit kinases once the receptor engages ligand.
The functional direction of a CD94-positive cell therefore cannot be inferred from CD94 staining alone. Two cells with identical CD94 intensity may be running opposite programs.
HLA-E as the Readout of Cellular Health
The CD94-NKG2 complex recognizes HLA-E, a non-classical MHC class I molecule known as Qa-1 in mice. HLA-E is unusual in what it presents.
Most of its peptide cargo derives from the signal sequences of classical MHC class I molecules. Surface HLA-E therefore reports the overall abundance of classical MHC class I, which in turn reports whether a cell is healthy.
Viruses that downregulate MHC class I to evade T cells also collapse HLA-E presentation, releasing NK cells from inhibition. This mechanism lets the NK compartment detect a broader range of evasion strategies than any single inhibitory receptor could cover.
Engagement adjusts cytotoxicity, cytokine secretion and survival of effector lymphocytes, so the complex acts as a tuning dial rather than a simple on-off switch.
What Knockout Models Revealed
Genetic models were expected to show a severe NK cell defect, and the results were more interesting than that prediction.
CD94-deficient mice have normal NK cell maturation in bone marrow, and the number and proportion of mature NK cells in spleen are unchanged. CD94 is therefore not required for development.
Function is also largely intact. CD94-deficient NK cells degranulate and produce interferon gamma at levels comparable to controls when stimulated. They also reject MHC class I-deficient target cells efficiently, which rules out global hyporesponsiveness.
Antiviral control is preserved as well. CD94-deficient mice lack the activating Ly49H receptor that normally mediates resistance, yet they still control mouse cytomegalovirus infection. Blocking NKG2A, NKG2C and NKG2E together has no effect on that control.
The pattern extends beyond cytomegalovirus. CD94-deficient mice clear lymphocytic choriomeningitis virus, Listeria monocytogenes and vaccinia virus with kinetics similar to wild-type animals.
Flow cytometry panels comparing NK cell populations across wild-type, CD94-deficient, CD94 transgenic and 129/SvJ strains
The conclusion is that CD94-NKG2 receptors fine-tune NK responses rather than provide an indispensable function, and that other receptors compensate when the complex is absent. That interpretation reframes CD94 as a modifier of thresholds, not a determinant of fate.
Where CD94 Measurement Changes an Experiment
The reagent matters most when the question concerns receptor balance rather than simple presence or absence.
In subset analysis, CD94 staining combined with CD56 and CD16 separates NK populations and reveals how receptor profiles differ between maturation stages. Absolute CD94 intensity is less informative than its distribution across subsets.
In paired analysis, CD94 is combined with NKG2A or NKG2C to estimate the proportion of inhibitory versus activating complexes. Because CD94 is shared between them, the pair of stains carries the biological meaning.
In education and tolerance studies, CD94-NKG2A expression is read alongside functional assays to test whether receptor acquisition matches functional competence. In antiviral work, CD94-positive NK cells are tracked for expansion and effector changes after infection.
Tumor immunology adds another setting, where CD94 and NKG2A are measured on tumor-infiltrating NK cells and CD8 T cells. High NKG2A expression in that context is usually interpreted as a checkpoint-like brake rather than a marker of maturation.
Designing a Panel That Can Be Interpreted
Three design rules prevent the most common errors.
Stain the NKG2 partner in the same panel. CD94 alone cannot distinguish inhibitory from activating assemblies, so a CD94-only figure supports a statement about expression and nothing more.
Match fluorophores to the cytometer rather than to brightness. A dim antigen on a poorly matched channel produces a negative result that reflects optics, not biology.
Include a fluorescence-minus-one control for each channel in the CD94 series. Compensation alone does not reveal spillover from a highly expressed neighboring marker, and the resulting false positive is easy to publish by accident.
FITC Anti-Human CD94 Antibodies
| Product Name | Catalog No. | Host | Clone | Conjugate | Application |
|---|---|---|---|---|---|
| FITC Mouse Anti-Human CD94 Antibody (HP-3D9) | S0B80489 | Mouse | HP-3D9 | FITC | Flow cytometry |
| FITC Rabbit Anti-Human CD94 Antibody (S-2616-17) | S0B80579 | Rabbit | S-2616-17 | FITC | Flow cytometry |
Both reagents are supplied for research use only and are formulated for direct staining of human cells. The mouse IgG1 clone and the recombinant rabbit clone provide alternative backbones for panels in which the secondary or isotype control strategy is already fixed.
Summary
CD94 is a shared subunit whose function is decided by its partner. The knockout literature shows that the resulting complexes adjust NK cell thresholds rather than control them outright. Interpreting CD94 data therefore requires the partner stain, a matched panel and an explicit statement about which assembly the signal represents.
ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs
ANT BIO PTE. LTD. supplies high-quality reagents and solutions for life science research. Our sub-brands cover the full research workflow: Starter for antibodies and immunological assay kits, UA-Bio for recombinant proteins and drug discovery solutions, and Absin for general reagents and other detection kits. Explore our product portfolio at www.antbioinc.com.
Disclaimer
This article was partially created with the assistance of artificial intelligence. If any content involves copyright or intellectual property issues, please inform us, and we promise to verify and remove it immediately.
